Matinas BioPharma Hldgs: Q1 Earnings Insights

Matinas BioPharma Hldgs MTNB reported its Q1 earnings results on Thursday, May 12, 2022 at 06:15 AM.

Here's what investors need to know about the announcement.

Matinas BioPharma Hldgs missed estimated earnings by 50.0%, reporting an EPS of $-0.03 versus an estimate of $-0.02.

Revenue was down $33.33 thousand from the same period last year.

Last quarter the company missed on EPS by $0.0 which was followed by a 7.04% increase in the share price the next day.

Here's a look at Matinas BioPharma Hldgs's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.03	-0.02	-0.03	-0.03
EPS Actual	-0.03	-0.03	-0.02	-0.03
Revenue Estimate	470.00K	1.53M	30.00K	20.00K
Revenue Actual	0	0	0	33.33K

To track all earnings releases for Matinas BioPharma Hldgs visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar